by Prateek Chopra | June 22, 2026 | Diabetes Conferences | ADA 2026 | 0 comments
Clinical Need
- Hypoglycemia remains a major cause of morbidity among people with diabetes, particularly those receiving insulin or sulfonylureas.
- Despite its clinical importance, hypoglycemia is often underrecognized in primary care settings, and preventive strategies remain underutilized.
Program Overview
- The Hypoglycemia Prevention Program (HPP) was evaluated as an EHR-integrated toolkit designed to improve hypoglycemia prevention in primary care.
- The pilot study enrolled adults with diabetes treated with insulin or sulfonylureas.
Intervention Components
- Patient Hypoglycemia Profile completed through the EHR before clinic visits.
- Provider Hypoglycemia Toolkit with EHR alerts and management recommendations.
- Patient education handout focused on hypoglycemia prevention.
Patient Participation
- Thirty-five participants were enrolled.
- Thirty-one participants (88.6%) completed the intervention.
Key Findings
- The HPP demonstrated high patient acceptability and low perceived burden.
- Glucagon prescribing increased significantly from 0% at baseline to 29% following implementation (p=0.004).
- Favorable trends toward reductions in hypoglycemia-related outcomes were observed, although statistical significance was not achieved.
Clinical Implications
- EHR-based tools may facilitate early identification of individuals at high risk for hypoglycemia.
- Integration of risk assessment and management strategies into routine care may improve hypoglycemia prevention practices.
The EHR-integrated HPP was well accepted by patients and improved hypoglycemia prevention practices in primary care. Further studies are warranted to determine its long-term impact on reducing hypoglycemic events.